Serum CCL18 is predictive for lung disease progression and mortality in systemic sclerosis

被引：55

作者：

Schupp, Jonas ^{[1
]}

Becker, Mike ^{[2
]}

Guenther, Jeannine ^{[2
]}

Mueller-Quernheim, Joachim ^{[1
]}

Riemekasten, Gabriela ^{[2
]}

Prasse, Antje ^{[1
]}

机构：

[1] Univ Hosp Freiburg, Med Ctr, Dept Pneumol, Freiburg, Germany

[2] Univ Hosp Charite Berlin, Dept Rheumatol & Clin Immunol, Berlin, Germany

来源：

EUROPEAN RESPIRATORY JOURNAL | 2014年 / 43卷 / 05期

关键词：

MACROPHAGE ACTIVATION; CHEMOKINE; PULMONARY;

D O I：

10.1183/09031936.00131713

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

100201 [内科学];

摘要：

引用

页码：1530 / 1532

页数：3

共 10 条

[1]

Can Serum Surfactant Protein D or CC-Chemokine Ligand 18 Predict Outcome of Interstitial Lung Disease in Patients with Early Systemic Sclerosis? [J].

Elhaj, Mona ;

Charles, Julio ;

Pedroza, Claudia ;

Liu, Xiaochun ;

Zhou, Xiaodong ;

Estrada-Y-Martin, Rosa M. ;

Gonzalez, Emilio B. ;

Lewis, Dorothy E. ;

Draeger, Hilda T. ;

Kim, Sarah ;

Arnett, Frank C. ;

Mayes, Maureen D. ;

Assassi, Shervin .

JOURNAL OF RHEUMATOLOGY, 2013, 40 (07) :1114-1120

[2]

European Respiratory Society, 2002, Am J Respir Crit Care Med, V165, P277, DOI [10.1164/ajrccm.165.2.ats01, DOI 10.1164/AJRCCM.165.2.ATS01]

[3]

The chemokine system in diverse forms of macrophage activation and polarization [J].

Mantovani, A ;

Sica, A ;

Sozzani, S ;

Allavena, P ;

Vecchi, A ;

Locati, M .

TRENDS IN IMMUNOLOGY, 2004, 25 (12) :677-686

[4]

Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population [J].

Mayes, MD ;

Lacey, JV ;

Beebe-Dimmer, J ;

Gillespie, BW ;

Cooper, B ;

Laing, TJ ;

Schottenfeld, D .

ARTHRITIS AND RHEUMATISM, 2003, 48 (08) :2246-2255

[5]

A vicious circle of alveolar macrophages and fibroblasts perpetuates pulmonary fibrosis via CCL18 [J].

Prasse, A ;

Pechkovsky, DV ;

Toews, GB ;

Jungraithmayr, W ;

Kollert, F ;

Goldmann, T ;

Vollmer, E ;

Müller-Quernheim, J ;

Zissel, G .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2006, 173 (07) :781-792

[6]

CCL18 as an indicator of pulmonary fibrotic activity in idiopathic interstitial pneumonias and systemic sclerosis [J].

Prasse, Antje ;

Pechkovsky, Dmitri V. ;

Toews, Galen B. ;

Schaefer, Markus ;

Eggeling, Stephan ;

Ludwig, Corinna ;

Germann, Martin ;

Kollert, Florian ;

Zissel, Gernot ;

Mueller-Quernheirn, Joachim .

ARTHRITIS AND RHEUMATISM, 2007, 56 (05) :1685-1693

[7]

Eosinophils and monocytes produce pulmonary and activation-regulated chemokine, which activates cultured monocytes/macrophages [J].

Schraufstatter, I ;

Takamori, H ;

Sikora, L ;

Sriramarao, P ;

DiScipio, RG .

AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2004, 286 (03) :L494-L501

[8]

INTERLEUKIN-4 POTENTLY ENHANCES MURINE MACROPHAGE MANNOSE RECEPTOR ACTIVITY - A MARKER OF ALTERNATIVE IMMUNOLOGICAL MACROPHAGE ACTIVATION [J].

STEIN, M ;

KESHAV, S ;

HARRIS, N ;

GORDON, S .

JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 176 (01) :287-292

[9]

Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee, 1980, ARTHRITIS RHEUM, V23, P581

[10]

Serum CC chemokine ligand-18 predicts lung disease worsening in systemic sclerosis [J].

Tiev, K. P. ;

Hua-Huy, T. ;

Kettaneh, A. ;

Gain, M. ;

Duong-Quy, S. ;

Toledano, C. ;

Cabane, J. ;

Dinh-Xuan, A. T. .

EUROPEAN RESPIRATORY JOURNAL, 2011, 38 (06) :1355-1360

← 1 →